Mayflower Bioscience
Private Company
Funding information not available
Overview
Mayflower Bioscience is a privately held, revenue-generating distributor founded in 2016, specializing in high-value research reagents, kits, and instruments for the life science sector. Its core business model is built on identifying and securing North American distribution rights for novel technologies developed primarily by European and other international companies. The company serves academic, biotech, and pharmaceutical researchers, with a product portfolio spanning oncology, infectious disease, and general cell and molecular biology applications. Its strategic value lies in its curated network of innovative suppliers and its US-based technical and customer support.
Technology Platform
A distribution and market access platform that sources, commercializes, and provides technical support for innovative life science research tools from global suppliers to the North American market.
Opportunities
Risk Factors
Competitive Landscape
Operates in a niche segment of the life science distribution market, competing against giants like Thermo Fisher and Merck by offering curated, unique products from smaller international companies. Its differentiator is specialized market access and US-based support for these novel tools.